Bleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management [PDF]
, 2004 David Bergqvist
openalex +1 more source
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]
, 2018 © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M +6 more
core +3 more sources
Евразийский Кардиологический Журнал, 2016 SUMMERY The main objective of the management of patients with atrial fibrillation (AF) is an effective prevention of ischemic stroke. For this purpose indirect and direct oral anticoagulants may be used.
A. V. Ardashev, I. V. Zotova
doaj +1 more source
Ximelagatran, direct thrombin inhibitor, oral anticoagulants, thromboprophylaxis [PDF]
, 2006 Shir‐Jing Ho, Tim Brighton
openalex +1 more source
The Italian Regulatory Guidelines for the implementation of Patient Blood Management [PDF]
, 2017 Comment in Towards the implementation of patient blood management across Europe.
Antonioli, Paola +8 more
core +1 more source
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis [PDF]
, 2007 Wolfgang Wienen +4 more
openalex +1 more source
Direct oral anticoagulants and travel-related venous thromboembolism
Open Medicine, 2018 Travel- related thromboembolism reflects the relationship between venous thromboembolism (VTE) and long-haul flights. Although this condition is rare, it may cause significant morbidity and mortality.
Chamnanchanunt Supat +1 more
doaj +1 more source
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials [PDF]
, 2012 Benjamin D. Fox +4 more
openalex +1 more source
Edoxaban in cardiovascular medicine from scientific evidence to clinical practice
Turkish Journal of Vascular Surgery, 2022 Direct oral anticoagulants have become a reasonable treatment option replacing warfarin in preventing stroke in patients with non-valvular atrial fibrillation and in treating and preventing venous thromboembolism.
Ali Baran Budak +4 more
doaj
Determination of Direct Oral Anticoagulants from Human Serum Samples [PDF]
, 2013 Sandra Kraemer +6 more
openalex +1 more source